Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-26

Clinical Trial Update: Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating rotigotine's effects on all-day functioning and quality of life in adults with moderate to severe restless legs syndrome; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neupro (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Restless Legs Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2014-08-26